Anika Therapeutics | ANIK - Market Capitalization


Anika Therapeutics reported $316M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
Agenus USD 3.19B 3.06B Aug/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 10.84B 664M Aug/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 10.91B 1.63B Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 19.68B 3.43B Aug/2026
Integra LifeSciences USD 1.4B 664M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Ligand Pharmaceuticals USD 5.31B 1.02B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Merit Medical Systems USD 4.14B 25M Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
Stryker USD 120.7B 5.15B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Xencor USD 1.21B 19M Aug/2026
Zimmer Biomet Holdings USD 20.17B 3.51B Aug/2026